Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1978 Feb;61(2):390–394. doi: 10.1172/JCI108949

Changes in Human Serum Amyloid A and C-Reactive Protein after Etiocholanolone-Induced Inflammation

Keith P W J McAdam 1,2,3,4, Ronald J Elin 1,2,3,4, Jean D Sipe 1,2,3,4, Sheldon M Wolff 1,2,3,4
PMCID: PMC372549  PMID: 621279

Abstract

Secondary amyloidosis is a complication of diseases characterized by recurrent acute inflammation. In this study, a standardized stimulus which induced fever and inflammation was given to six normal subjects (19-24 yr old) to follow the fluctuation in concentration of serum amyloid A (SAA), the precursor of the secondary amyloid fibril protein. After a single intramuscular injection of etiocholanolone (0.3 mg/kg), blood samples were drawn twice a day for 12 days for determination of SAA by solid phase radioimmunoassay. From a base line of <100 μg/ml, the SAA concentration began rising within 12 h to a maximum value at about 48 h of 1,350-1,800 μg/ml in three males and 380-900 μg/ml in three females and returned to base line by 4-5 days. The SAA response showed a similar time response to C-reactive protein (CRP), a well-documented acute phase protein which was assayed semiquantitatively by capillary tube precipitin reaction. CRP, but not SAA, showed a quantitative correlation with the amount of fever induced by etiocholanolone. One subject exhibited a second rise in SAA and CRP concentrations after acute over-indulgence with alcohol, suggesting that acute liver damage may have caused an acute phase reaction. Thus, a controlled episode of fever and inflammation produced a prompt and prolonged elevation of SAA and CRP concentrations. Unlike SAA, CRP has not been implicated in the pathogenesis of amyloidosis, although its relationship to the P component of amyloid has recently been established.

Full text

PDF
390

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON H. C., McCARTY M. Determination of C-reactive protein in the blood as a measure of the activity of the disease process in acute rheumatic fever. Am J Med. 1950 Apr;8(4):445–455. doi: 10.1016/0002-9343(50)90226-9. [DOI] [PubMed] [Google Scholar]
  2. Anders R. F., Natvig J. B., Sletten K., Husby G., Nordstoga K. Amyloid-related serum protein SAA from three animal species: comparison with human SAA. J Immunol. 1977 Jan;118(1):229–234. [PubMed] [Google Scholar]
  3. Benson M. D., Aldo-Benson M. A., Shirahama T., Borel Y., Cohen A. S. Suppression of in vitro antibody response by a serum factor (SAA) in experimentally induced amyloidosis. J Exp Med. 1975 Jul 1;142(1):236–241. doi: 10.1084/jem.142.1.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Croft S. M., Mortensen R. F., Gewurz H. Binding of C-reactive protein to antigen-induced but not mitogen-induced T lymphoblasts. Science. 1976 Aug 20;193(4254):685–687. doi: 10.1126/science.1085034. [DOI] [PubMed] [Google Scholar]
  5. Franklin E. C. Some properties of antisera to serum amyloid A protein (SAA): inhibition of precipitation by complexing of SAA to albumin. J Exp Med. 1976 Dec 1;144(6):1679–1682. doi: 10.1084/jem.144.6.1679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Glenner G. G., Page D. L. Amyloid, amyloidosis, and amyloidogenesis. Int Rev Exp Pathol. 1976;15:1–92. [PubMed] [Google Scholar]
  7. Hurlimann J., Thorbecke G. J., Hochwald G. M. The liver as the site of C-reactive protein formation. J Exp Med. 1966 Feb 1;123(2):365–378. doi: 10.1084/jem.123.2.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Husby G., Natvig J. B. A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest. 1974 Apr;53(4):1054–1061. doi: 10.1172/JCI107642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Levin M., Pras M., Franklin E. C. Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component. J Exp Med. 1973 Aug 1;138(2):373–380. doi: 10.1084/jem.138.2.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Levo Y., Frangione B., Franklin E. C. Amino acid sequence similarities between amyloid P component C1t and CRP. Nature. 1977 Jul 7;268(5615):56–57. doi: 10.1038/268056a0. [DOI] [PubMed] [Google Scholar]
  11. Linke R. P., Sipe J. D., Pollock P. S., Ignaczak T. F., Glenner G. G. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1473–1476. doi: 10.1073/pnas.72.4.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mannik M., Arend M. P., Hall A. P., Gilliland B. C. Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation. J Exp Med. 1971 Apr 1;133(4):713–739. doi: 10.1084/jem.133.4.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McAdam K. P., Anders R. F., Smith S. R., Russell D. A., Price M. A. Association of amyloidosis with erythema nodosum leprosum reactions and recurrent neutrophil leucocytosis in leprosy. Lancet. 1975 Sep 27;2(7935):572–573. doi: 10.1016/s0140-6736(75)90168-3. [DOI] [PubMed] [Google Scholar]
  14. Osmand A. P., Friedenson B., Gewurz H., Painter R. H., Hofmann T., Shelton E. Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc Natl Acad Sci U S A. 1977 Feb;74(2):739–743. doi: 10.1073/pnas.74.2.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rosenthal C. J., Franklin E. C., Frangione B., Greenspan J. Isolation and partial characterization of SAA-an amyloid-related protein from human serum. J Immunol. 1976 May;116(5):1415–1418. [PubMed] [Google Scholar]
  16. Rosenthal C. J., Franklin E. C. Variation with age and disease of an amyloid A protein-related serum component. J Clin Invest. 1975 Apr;55(4):746–753. doi: 10.1172/JCI107985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sipe J. D., Ignaczak T. F., Pollock P. S., Glenner G. G. Amyloid fibril protein AA: purification and properties of the antigenically related serum component as determined by solid phase radioimmunoassay. J Immunol. 1976 Apr;116(4):1151–1156. [PubMed] [Google Scholar]
  18. Sipe J. D., McAdam K. P., Torain B. F., Glenner G. G. Conformational flexibility of the serum amyloid precursor SAA. Br J Exp Pathol. 1976 Oct;57(5):582–592. [PMC free article] [PubMed] [Google Scholar]
  19. Skinner M., Cohen A. S., Shirahama T., Cathcart E. S. P-component (pentagonal unit) of amyloid: isolation, characterization, and sequence analysis. J Lab Clin Med. 1974 Oct;84(4):604–614. [PubMed] [Google Scholar]
  20. WOLFF S. M., RUBENSTEIN M., MULHOLLAND J. H., ALLING D. W. COMPARISON OF HEMATOLOGIC AND FEBRILE RESPONSE TO ENDOTOXIN IN MAN. Blood. 1965 Aug;26:190–201. [PubMed] [Google Scholar]
  21. Westermark P., Natvig J. B., Anders R. F., Sletten K., Husby G. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils. Scand J Immunol. 1976;5(1-2):31–36. doi: 10.1111/j.1365-3083.1976.tb02989.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES